OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Liquid Biopsies in Cancer Diagnosis, Monitoring, and Prognosis
Gabriele De Rubis, Sabna Rajeev Krishnan, Mary Bebawy
Trends in Pharmacological Sciences (2019) Vol. 40, Iss. 3, pp. 172-186
Open Access | Times Cited: 454

Showing 1-25 of 454 citing articles:

Update on Fundamental Mechanisms of Thyroid Cancer
Alessandro Prete, Patricia Borges de Souza, Simona Censi, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 356

Applications of single-cell sequencing in cancer research: progress and perspectives
Yalan Lei, Rong Tang, Jin Xu, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 344

Liquid biopsies: the future of cancer early detection
Siobhan Connal, James M. Cameron, Alexandra Sala, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 163

DNA in extracellular vesicles: biological and clinical aspects
Julia Elzanowska, Christine Semira, Bruno Costa‐Silva
Molecular Oncology (2020) Vol. 15, Iss. 6, pp. 1701-1714
Open Access | Times Cited: 144

The potential of using blood circular RNA as liquid biopsy biomarker for human diseases
Guoxia Wen, Tong Zhou, Wanjun Gu
Protein & Cell (2020) Vol. 12, Iss. 12, pp. 911-946
Open Access | Times Cited: 138

Synthetic biomarkers: a twenty-first century path to early cancer detection
Gabriel A. Kwong, Sharmistha Ghosh, Lena Gamboa, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 10, pp. 655-668
Open Access | Times Cited: 133

Plasma-derived exosomal miR-15a-5p as a promising diagnostic biomarker for early detection of endometrial carcinoma
Lanyun Zhou, Wei Wang, Fenfen Wang, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 111

Liquid Biopsy as a Tool for the Diagnosis, Treatment, and Monitoring of Breast Cancer
Ana Julia Aguiar de Freitas, Rhafaela Lima Causin, Muriele Bertagna Varuzza, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9952-9952
Open Access | Times Cited: 69

Liquid Biopsies, Novel Approaches and Future Directions
Athanasios Armakolas, Maria Kotsari, John Koskinas
Cancers (2023) Vol. 15, Iss. 5, pp. 1579-1579
Open Access | Times Cited: 66

New insights into the correlations between circulating tumor cells and target organ metastasis
Qinru Zhan, Bixia Liu, Xiaohua Situ, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 50

Molecularly imprinted polymers (MIPs): emerging biomaterials for cancer theragnostic applications
Min Seok Kang, Euni Cho, Hye Eun Choi, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 46

MitoEVs: A new player in multiple disease pathology and treatment
Xiyue Zhou, Shuyun Liu, Yanrong Lu, et al.
Journal of Extracellular Vesicles (2023) Vol. 12, Iss. 4
Open Access | Times Cited: 45

Recent advances of liquid biopsy: Interdisciplinary strategies toward clinical decision‐making
Han Bao, Li Min, Fanqin Bu, et al.
Deleted Journal (2023) Vol. 1, Iss. 4
Open Access | Times Cited: 42

Emerging Multifunctional Carbon‐Nanomaterial‐Based Biosensors for Cancer Diagnosis
Jolitta Sheri John Britto, Xinwei Guan, Thi Kim Anh Tran, et al.
Small Science (2024) Vol. 4, Iss. 3
Open Access | Times Cited: 18

Novel therapeutic agents in clinical trials: emerging approaches in cancer therapy
Deepak Chandra Joshi, Anurag Sharma, Sonima Prasad, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 18

Current smartphone-assisted point-of-care cancer detection: Towards supporting personalized cancer monitoring
Linh Thi Phuong Le, Anh Hoang Quan Nguyen, Le Minh Tu Phan, et al.
TrAC Trends in Analytical Chemistry (2024) Vol. 174, pp. 117681-117681
Closed Access | Times Cited: 15

Extracellular vesicles as a novel source of biomarkers in liquid biopsies for monitoring cancer progression and drug resistance
M. Helena Vasconcelos, Hugo R. Caires, Artūrs Ābols, et al.
Drug Resistance Updates (2019) Vol. 47, pp. 100647-100647
Closed Access | Times Cited: 127

Tumor circulome in the liquid biopsies for cancer diagnosis and prognosis
Jicheng Wu, Shen Hu, Lihong Zhang, et al.
Theranostics (2020) Vol. 10, Iss. 10, pp. 4544-4556
Open Access | Times Cited: 123

Clonal Hematopoiesis in Liquid Biopsy: From Biological Noise to Valuable Clinical Implications
Ting Chan, Yoon Ming Chin, Yusuke Nakamura, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2277-2277
Open Access | Times Cited: 115

Circulating tumor cells in precision oncology: clinical applications in liquid biopsy and 3D organoid model
Chang Yang, Bairong Xia, Weilin Jin, et al.
Cancer Cell International (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 110

Recent developments in electrochemiluminescence nanosensors for cancer diagnosis applications
Yantao Fu, Qiang Ma
Nanoscale (2020) Vol. 12, Iss. 26, pp. 13879-13898
Closed Access | Times Cited: 96

Lessons to learn from tumor-educated platelets
Harvey G. Roweth, Elisabeth M. Battinelli
Blood (2021) Vol. 137, Iss. 23, pp. 3174-3180
Open Access | Times Cited: 96

Updates on liquid biopsy: current trends and future perspectives for clinical application in solid tumors
Pamela Pinzani, Valeria D’Argenio, Marzia Del Re, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2021) Vol. 59, Iss. 7, pp. 1181-1200
Open Access | Times Cited: 90

Page 1 - Next Page

Scroll to top